Profit

Drug Pricing Controls Detrimental: Kiran Mazumdar-Shaw

PUBLISHED ON: July 16, 2014 | Duration: 7 min, 41 sec

  
loading..
Kiran Mazumdar-Shaw, CMD of Biocon, tells NDTV that the NPPA's decision to add more drugs under price control will have a detrimental impact on the industry and the pharmaceutical sector has been completely overlooked in this Budget.
ALSO WATCH
"Looks Like Diwali Has Come Early": India Inc. Cheers Corporate Tax Cut

................................ Advertisement ................................

................................ Advertisement ................................